Synova

Synova Life Sciences is a biotechnology company specializing in regenerative medicine through its proprietary Direct-to-Stem (DTS) platform. The company's technology enables the rapid, automated extraction of high-quality stem cells from adipose tissue in minutes, significantly reducing the time and complexity compared to traditional enzymatic methods. Synova's primary focus is on developing point-of-care autologous stem cell therapies for orthopedic indications, particularly osteoarthritis, while also exploring applications in tissue engineering and cellular agriculture. By preserving the regenerative properties of patient-derived cells, the company aims to transform the treatment of degenerative conditions and promote efficient tissue repair.